AMIVANTAMAB

UNII:	0JSR7Z0NB6
Formula:
Preferred Substance Name:	AMIVANTAMAB

2171511-58-1
AMIVANTAMAB [INN]
AMIVANTAMAB [JAN]
AMIVANTAMAB [WHO-DD]
AMIVANTAMAB VMJW [WHO-DD]
AMIVANTAMAB-VMJW
ANTI-EGFR/C-MET BISPECIFIC ANTIBODY JNJ-61186372
CNTO-4424
IMMUNOGLOBULIN G1 (413-LYSINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL JNJ-61186372 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JNJ-61186372 .KAPPA.-CHAIN, (234->228'),(237->231')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (411-ARGININE) ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET) HUMAN MONOCLONAL JNJ-61186372 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL JNJ-61186372 .KAPPA.-CHAIN
JNJ-611
JNJ-61186372
RYBREVANT

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

AMIVANTAMAB

Synonyms and Mappings

Resources